Simplex Trading
RANI icon

Simplex Trading’s Rani Therapeutics RANI Stock Holding History

Simplex Trading’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.42K Buy
+10,101
New +$12.9K ﹤0.01% 7609
2025
Q4 		– Sell
-819
Closed -$1.24K – 9798
2025
Q3 		$0 Buy
+819
New +$427 ﹤0.01% 9871
2024
Q4 		– Sell
-2,835
Closed -$5.96K – 9422
2024
Q3 		$6K Buy
2,835
+1,353
+91% +$3.88K ﹤0.01% 7546
2024
Q2 		$5K Buy
1,482
+118
+9% +$611 ﹤0.01% 7895
2024
Q1 		$4K Sell
1,364
-7,772
-85% -$26.7K ﹤0.01% 8153
2023
Q4 		$30K Buy
9,136
+7,893
+635% +$18.3K ﹤0.01% 6564
2023
Q3 		$2K Sell
1,243
-308
-20% -$1.18K ﹤0.01% 8146
2023
Q2 		$6K Buy
1,551
+1,206
+350% +$5.6K ﹤0.01% 7822
2023
Q1 		$1K Buy
345
+45
+15% +$271 ﹤0.01% 8753
2022
Q4 		$1K Buy
300
+78
+35% +$569 ﹤0.01% 8898
2022
Q3 		$2K Buy
+222
New +$2.35K ﹤0.01% 9337

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Simplex Trading's RANI Position: Q1 2026 in Review

Simplex Trading opened a new position in Rani Therapeutics (RANI) in Q1 2026: 10,101 shares worth $7.42K. The stake represents ﹤0.01% of the portfolio and ranks #7609 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RANI as recently as Q3 2025.

Simplex Trading first reported a position in RANI in Q3 2022 and has held it in 11 quarters since. The position peaked at $30K in Q4 2023. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Simplex Trading held 10,101 shares of Rani Therapeutics worth $7.42K as of Q1 2026.
  • Rani Therapeutics was a new Simplex Trading position in Q1 2026.
  • Rani Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7609 holding.
  • Simplex Trading first reported a position in Rani Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • Simplex Trading's Rani Therapeutics position peaked at $30K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.